The rising interest in GLP-1 agonists for diabetes has sparked a discussion about formats: skin-applied devices versus tablets . Traditionally , GLP-1 treatments were exclusively available in oral form, but https://junaidgkrg751538.blogaritma.com/38869960/glp-1-skin-applications-vs-pills-what-suitable-for-the-patient